BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36254563)

  • 1. Prostate cancer-related anxiety among long-term survivors after radical prostatectomy: A longitudinal study.
    Meissner VH; Peter C; Ankerst DP; Schiele S; Gschwend JE; Herkommer K; Dinkel A
    Cancer Med; 2023 Feb; 12(4):4842-4851. PubMed ID: 36254563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
    Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K
    BMC Urol; 2023 Aug; 23(1):139. PubMed ID: 37612591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.
    Meissner VH; Herkommer K; Marten-Mittag B; Gschwend JE; Dinkel A
    J Cancer Surviv; 2017 Dec; 11(6):800-807. PubMed ID: 28528448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: A longitudinal study.
    Meissner VH; Olze L; Schiele S; Ankerst DP; Jahnen M; Gschwend JE; Herkommer K; Dinkel A
    Cancer; 2021 Nov; 127(22):4287-4295. PubMed ID: 34358337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment decision regret in long-term survivors after radical prostatectomy: a longitudinal study.
    Meissner VH; Simson BW; Dinkel A; Schiele S; Ankerst DP; Lunger L; Gschwend JE; Herkommer K
    BJU Int; 2023 May; 131(5):623-630. PubMed ID: 36545828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
    Adam S; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mohsen Mousavi S; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Arndt V
    Cancer Med; 2020 Aug; 9(15):5416-5424. PubMed ID: 32524704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
    Hoffman RM; Lo M; Clark JA; Albertsen PC; Barry MJ; Goodman M; Penson DF; Stanford JL; Stroup AM; Hamilton AS
    J Clin Oncol; 2017 Jul; 35(20):2306-2314. PubMed ID: 28493812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.
    Chow K; Herrera P; Stuchbery R; Peters JS; Costello AJ; Hovens CM; Corcoran NM
    BJU Int; 2019 Jun; 123(6):976-984. PubMed ID: 30248237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of quality of life and late biochemical predictors for localized cancer recurrence following radical prostatectomy.
    Friedersdorff F; Buckendahl L; Alt L; Maxeiner A; Hinz S; Bichmann A; Miller K; Magheli A; Busch J
    World J Urol; 2020 Jun; 38(6):1501-1507. PubMed ID: 31463559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; RoumiguiƩ M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
    Drummond FJ; Kinnear H; O'Leary E; Donnelly ; Gavin A; Sharp L
    J Cancer Surviv; 2015 Jun; 9(2):361-72. PubMed ID: 25563819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.
    Adam S; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Rohrmann S; Brenner H; Arndt V
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13076. PubMed ID: 31050091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
    Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
    Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
    Briganti A; Karnes RJ; Joniau S; Boorjian SA; Cozzarini C; Gandaglia G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Sun M; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
    Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.